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Intravenous penetration of fluconazole during 
endophthalmitis 
Clin Microbiol Infect 1997; 3: 143-144 
A recent article by Akler et al. summarized 27 cases of 
fluconazole-treated candidal endophthalmitis reported 
in the Enghsh language literature [l]. Fluconazole was 
the sole therapy in 14 patients, and a favorable outcome 
was obtained in 15 of 16 eyes, including five infections 
that were complicated by vitreitis; however, ocular 
penetration of fluconazole was not evaluated. Although 
the high vitreous penetration of fluconazole is generally 
considered to be responsible for the favorable clinical 
outcome, data on vitreous fluconazole concentrations 
in humans have been reported only twice [2]. We 
have assessed fluconazole penetration into the vitreous 
humor of a patient with endophthalmitis. 
A 27-year-old male heroin addict, weighing 78 kg, 
having normal renal function, was hospitalized in 
August 1994 for blurred vision in the left eye. Ocular 
examination revealed chorioretinal lesions compatible 
with candidal endophthalmitis and vitreitis. Angio- 
graphy confirmed the diagnosis, but direct examination 
and mycologic cultures of the vitreous humor remained 
negative. Treatment consisted of four intravitreous 
injections of amphotericin B at 48-h intervals and 
fluconazole 200 mg twice-daily intravenously for 1 
month and then orally for 2 months. Vitrectomy was 
performed in the third week because of severe vitreitis. 
Two vitreous samples (days 4 and 11) and one serum 
sample (day 7) were obtained about 3 h after the pre- 
vious dose. Fluconazole concentrations were measured 
by reverse-phase liquid chromatography with absor- 
bance detection at 260 nm, either by direct injection of 
the vitreous humor samples or after liquid-liquid 
extraction in the case of the plasma samples. The 
vitreous fluconazole concentrations on days 4 and 
11 were 10.4 and 11.9 mg/L, respectively, while the 
plasma concentration on day 7 was 15.0 mg/L. The 
retina of the infected eye became detached in the 
fifth week. The infection resolved completely and no 
relapse had occurred after more than 10 months of 
In samples taken 3 h after drug administration, the 
vitreous fluconazole concentration was 69-79% of that 
measured in plasma. These results are very similar 
to those reported earlier [2]. Since the fluconazole 
elimination half-life is about 30 h, the steady state 
should have been attained by day 5 of treatment. 
Theoretically if fluconazole penetration into vitreous 
humor were accomplished solely by passive diffusion, 
its vitreous concentration at steady state would be equal 
to that of the free fraction in plasma (89% in humans 
with normal renal function). The difference from the 
measured values is small and probably not significant. 
Therefore, fluconazole-protein binding may be a 
major factor controlling drug penetration into vitreous 
humor. This possibility is important because fluco- 
nazole-protein binding has been shown to depend on 
the al-acid glycoprotein level and to be increased from 
11% in normal subjects to 22% in chronic renal failure 
patients treated by hemodialysis [3], and this enhanced 
protein binding could result in lower fluconazole 
penetration into the eye. Although no relationship has 
been established between the fluconazole concen- 
tration in body fluids and in vivo antifungal activity, 
indirect arguments suggest that such a relationship 
does exist for other azole compounds, such as keto- 
conazole [4] and itraconazole [5]. 
follow-up. 
1 4 4  Clinical Microbio logy and Infection, Volume 3 Number  1, February 1997 
Finally, available pharmacohnetic data in humans 
are not adequate to define an optimal dosage schedule 
for fluconazole in endophthahitis. However, owing 
to its long half-life and high bioavailability, once- 
daily adrmnistration by the oral or intravenous route 
should be equally effective in treating candidal endo- 
phthalmitis. Because the fluconazole levels achieved 
in the vitreous humor are proportional to the dose 
in the 200- to 400-mg range (data on other dosages 
have not been reported), it is possible that higher 
doses would produce higher vitreous levels and better 
efficacy. 
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Comparison of two DNA extraction methods on inhibitory 
sputum samples 
Clin Microbiol Infect 1997; 3: 144-145 
The polymerase chain reaction (PCR) is a promising 
method in the rapid diagnosis of Mycobacterium tuber- 
culosis infections. However, ongoing problems such 
as contamination and inhibition have prevented its 
widespread use in routine practice. Contamination 
occurs primarily from two sources: total genomic DNA 
&om other samples or from cultures in the same 
laboratory, and the small amplified products carried 
over fiom previous PCR assays. Inhibition is mainly 
due to some, as yet unknown, substances s d  present 
with DNA after extraction. Inhibition, which has been 
reported as 10-20%, must be monitored by internal or 
external controls [1,2]. These extra tests or repetitions 
of the assay increase the costs. Contamination and 
inhibition are the problems of the DNA extraction 
phase. Complex extraction procedures are more prone 
to contamination; on the other hand, simple methods 
fail to eliminate the inhibitors. Therefore, the ideal 
extraction method should be simple enough to avoid 
contamination, yet effective in eliminating the inhibi- 
tory substances. Several DNA extraction methods have 
been proposed for routine practice, but none of these 
has yet been tested for effectiveness in eliminating the 
inhibitors. 
We compared two DNA extraction methods applied 
to samples which had shown inhibition: a simple chloro- 
form extraction [3] and a guanidium duocyanate-silica 
(GuSCN-silica) method [4]. Briefly, 50 pL of chloro- 
form was added to 200 pL aliquots, followed by heat 
inactivation at 80°C for 20 min in 1.5-mL Eppendorf 
tubes. The heat-inactivated samples were centrifuged 
at 12 OOOg for 2 min. Ten-microliter amounts of the 
aqueous supernatants were subjected to PCR. The 
second method is incorporated in a new kit (QIAamp; 
DiagenGmbH GildenIGermany) , designed for nucleic 
acid extraction from clinical samples. The method 
depends mainly on the lytic effect of the chaothropic 
agent GuSCN and proteinase K and the capture of 
nucleic acids @As) under high-salt conditions by silica. 
Briefly, 200 pL of the sample is mixed with 200 pL 
of lysis solution and incubated at 80°C for 20 min. 
After a wash step, NA is eluted by disdled water. The 
procedure can be completed w i t h  30 min. Genomic 
DNA binds to silica in the presence of GuSCN and so 
it has been suggested that inhibitors would be removed 
during the washing steps. To determine the samples 
with inhibitory effects, we seeded 50 sputa with lo7 
M. tuberculosis and prepared DNA simply by boillng 
half the sediment in distilled water. The remainder was 
stored at -20°C. Nine of these 50 samples inhibited 
the PCR reaction, as judged by negative amplification 
results. To compare the effectiveness of the two 
extraction methods (chloroform and GuSCN-silica 
methods), the stored sediments from inhibitory sputum 
samples were thawed and divided into equal aliquots 
and were processed by the two extraction methods 
separately. We amplified a 123-bp & p e n t  of IS61 10 
repetitive insertion element. The conditions for the 
PCR have been described in detail elsewhere [5]. 
The extracts that s t i l l  inhibited the reaction after the 
